PAWNBROKER Web Results

An update on SARS-CoV-2 prevention strategy in solid organ transplant ... To protect transplanted patients against severe COVID-19, two primary preventive strategies have been proposed: anti-SARS-CoV-2 vaccination and pre-exposure prophylaxis (PrEP) with monoclonal antibodies that possess neutralizing activity against SARS-CoV-2.

COVID-19: Issues related to solid organ transplantation This topic reviews aspects of COVID-19 that are specific to solid organ transplantation, including screening prior to transplantation, distinct clinical features, managing immunosuppression, and important drug interactions.

COVID-19 and Transplant Patients: Challenges, Risks, and Evolving ... Early treatments focused on managing symptoms and preventing severe complications. The COVID-19 pandemic posed significant challenges to the global healthcare system, especially in vulnerable populations such as solid organ transplant (SOT) recipients.

COVID-19 Task Force | American Society of Transplantation The COVID-19 Task Force provides information and resources on the practice and clinical implications of COVID-19 on transplant patients, donors, and practitioners.

Coronavirus Disease 2019 Management Strategies in Solid Organ ... Among patients with severe and critical COVID-19, treatment with intravenous remdesivir and immunomodulation is recommended. This review article discusses strategies in the management of solid organ transplant recipients with COVID-19.

Early administration of SARS‐CoV‐2 monoclonal antibody reduces the risk ... Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.

COVID-19 Hospitalization in Organ Transplant Recipients on ... Among them, 12.7% of kidney transplant recipients, 6.4% of liver transplant recipients, 12.9% of heart transplant recipients, and 18.0% of lung transplant recipients were hospitalized for COVID-19.

Study: Solid Organ Transplant Patients Benefit From COVID-19 Treatment To limit the risk of COVID-19 infection, study investigators recommend that solid organ transplant patients continue to wear masks in public places and avoid contact with individuals who are coughing or have had known contact with patients who have COVID-19.

Impact of COVID-19 in solid organ transplant recipients The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early 2020. The impact on solid organ transplantation (SOT) has been profound affecting potential donors, candidates, and recipients.

Frontiers | COVID-19 in solid organ transplant recipients after 2 years ... This study aims to describe the outcome of COVID-19 in a cohort of solid organ transplant recipients and the impact of novel antivirals against SARS-CoV-2. We conducted an observational retrospective cohort study.